Synopsys, Inc. $SNPS Shares Bought by GFG Capital LLC

GFG Capital LLC lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 23.8% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 7,909 shares of the semiconductor company’s stock after buying an additional 1,523 shares during the quarter. GFG Capital LLC’s holdings in Synopsys were worth $3,440,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. BlackRock Inc. bought a new stake in shares of Synopsys during the second quarter worth approximately $7,228,099,000. Van ECK Associates Corp grew its position in shares of Synopsys by 19.7% in the second quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock valued at $1,542,175,000 after purchasing an additional 569,687 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Synopsys by 40.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock valued at $1,377,174,000 after purchasing an additional 892,736 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in shares of Synopsys by 11.2% during the third quarter. Assenagon Asset Management S.A. now owns 2,729,988 shares of the semiconductor company’s stock worth $1,187,381,000 after purchasing an additional 274,586 shares during the period. Finally, Amundi increased its stake in shares of Synopsys by 3.6% during the first quarter. Amundi now owns 1,761,983 shares of the semiconductor company’s stock worth $698,591,000 after purchasing an additional 61,077 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on SNPS. Roth Capital upgraded Synopsys to a “buy” rating in a research note on Friday, September 25th. KeyCorp increased their price objective on Synopsys from $600.00 to $605.00 and gave the stock an “overweight” rating in a research report on Thursday, October 1st. Morgan Stanley dropped their target price on Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a report on Wednesday, August 19th. Wells Fargo & Company lifted their target price on Synopsys from $475.00 to $540.00 and gave the stock an “overweight” rating in a report on Thursday, October 1st. Finally, HSBC cut shares of Synopsys from a “buy” rating to a “reduce” rating in a research report on Friday, September 25th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, Synopsys presently has an average rating of “Moderate Buy” and an average price target of $571.78.

Insiders Place Their Bets

In other Synopsys news, insider Aart de Geus sold 25,000 shares of Synopsys stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $441.76, for a total value of $11,044,000.00. Following the transaction, the insider owned 120,421 shares in the company, valued at $53,197,180.96. The trade was a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,604 shares of Synopsys stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the sale, the chief executive officer directly owned 76,865 shares in the company, valued at $28,815,151.20. This trade represents a 15.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 117,163 shares of company stock worth $51,366,457 over the last 90 days. Corporate insiders own 0.56% of the company’s stock.

Synopsys Stock Down 2.9%

Shares of SNPS opened at $454.63 on Friday. The firm has a 50 day simple moving average of $427.56 and a two-hundred day simple moving average of $441.51. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. Synopsys, Inc. has a one year low of $362.55 and a one year high of $539.48. The company has a market cap of $87.13 billion, a P/E ratio of 80.32, a P/E/G ratio of 1.91 and a beta of 1.21.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company’s revenue was up 42.4% compared to the same quarter last year. During the same quarter last year, the business posted $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Research analysts forecast that Synopsys, Inc. will post 10.97 EPS for the current fiscal year.

Synopsys declared that its board has initiated a stock buyback plan on Monday, October 5th that allows the company to repurchase $1.00 billion in outstanding shares. This buyback authorization allows the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Share buyback plans are generally a sign that the company’s management believes its stock is undervalued.

Synopsys Company Profile

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.